183 related articles for article (PubMed ID: 12421263)
1. Investigation of risk factors for tonsillopharyngitis with macrolide resistant Streptococcus pyogenes in Turkish children.
Ciftçi E; Dogru U; Güriz H; Aysev D; Ince E
Pediatr Int; 2002 Dec; 44(6):647-51. PubMed ID: 12421263
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of Streptococcus pyogenes to two macrolides in northern Israel.
Sakran W; Raz R; Chazan B; Koren A; Colodner R
Int J Antimicrob Agents; 2004 May; 23(5):517-9. PubMed ID: 15120735
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of 5-day therapy with telithromycin, a novel ketolide antibacterial, for the treatment of tonsillopharyngitis.
Norrby SR; Quinn J; Rangaraju M; Leroy B
Clin Microbiol Infect; 2004 Jul; 10(7):615-23. PubMed ID: 15214873
[TBL] [Abstract][Full Text] [Related]
4. Phenotypes of macrolide resistance of group A streptococci isolated from outpatients in Bavaria and susceptibility to 16 antibiotics.
Sauermann R; Gattringer R; Graninger W; Buxbaum A; Georgopoulos A
J Antimicrob Chemother; 2003 Jan; 51(1):53-7. PubMed ID: 12493787
[TBL] [Abstract][Full Text] [Related]
5. Erythromycin resistance in Streptococcus pyogenes in Italy.
Bassetti M; Manno G; Collidà A; Ferrando A; Gatti G; Ugolotti E; Cruciani M; Bassetti D
Emerg Infect Dis; 2000; 6(2):180-3. PubMed ID: 10756153
[TBL] [Abstract][Full Text] [Related]
6. High macrolide resistance in Streptococcus pyogenes strains isolated from children with pharyngitis in China.
Liu X; Shen X; Chang H; Huang G; Fu Z; Zheng Y; Wang L; Li C; Liu L; Shen Y; Yang Y
Pediatr Pulmonol; 2009 May; 44(5):436-41. PubMed ID: 19360846
[TBL] [Abstract][Full Text] [Related]
7. Utilisation of macrolides and the development of Streptococcus pyogenes resistance to erythromycin.
Urbánek K; Kolár M; Cekanová L
Pharm World Sci; 2005 Apr; 27(2):104-7. PubMed ID: 15999920
[TBL] [Abstract][Full Text] [Related]
8. [Current Streptococcus pyogenes sensitivity responsible for acute tonsillopharyngitis in France].
Mariani-Kurkdjian P; Doit C; Deforche D; Brahimi N; Francois M; Van den Abbeele T; Bingen E
Presse Med; 2004 Jun; 33(11):703-6. PubMed ID: 15257225
[TBL] [Abstract][Full Text] [Related]
9. Two dosages of clarithromycin for five days, amoxicillin/clavulanate for five days or penicillin V for ten days in acute group A streptococcal tonsillopharyngitis.
Syrogiannopoulos GA; Bozdogan B; Grivea IN; Ednie LM; Kritikou DI; Katopodis GD; Beratis NG; Applebaum PC;
Pediatr Infect Dis J; 2004 Sep; 23(9):857-65. PubMed ID: 15361727
[TBL] [Abstract][Full Text] [Related]
10. Group A streptococcal tonsillopharyngitis: cost-effective diagnosis and treatment.
Pichichero ME
Ann Emerg Med; 1995 Mar; 25(3):390-403. PubMed ID: 7864482
[TBL] [Abstract][Full Text] [Related]
11. Nationwide survey in Italy of treatment of Streptococcus pyogenes pharyngitis in children: influence of macrolide resistance on clinical and microbiological outcomes. Artemis-Italy Study Group.
Varaldo PE; Debbia EA; Nicoletti G; Pavesio D; Ripa S; Schito GC; Tempera G
Clin Infect Dis; 1999 Oct; 29(4):869-73. PubMed ID: 10589905
[TBL] [Abstract][Full Text] [Related]
12. Treatment of pediatric patients with acute group A beta-hemolytic streptococcal tonsillopharyngitis.
Jakob-Sölder B; Steininger C; Eigentler A; Allerberger F
Eur J Clin Microbiol Infect Dis; 1998 Nov; 17(11):811-2. PubMed ID: 9923529
[No Abstract] [Full Text] [Related]
13. Comparison of 5 days of extended-release clarithromycin versus 10 days of penicillin V for the treatment of streptococcal pharyngitis/tonsillitis: results of a multicenter, double-blind, randomized study in adolescent and adult patients.
Takker U; Dzyublyk O; Busman T; Notario G
Curr Med Res Opin; 2003; 19(5):421-9. PubMed ID: 13678479
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenes collected in Austria and Hungary.
Gattringer R; Sauermann R; Lagler H; Stich K; Buxbaum A; Graninger W; Georgopoulos A
Int J Antimicrob Agents; 2004 Sep; 24(3):290-3. PubMed ID: 15325435
[TBL] [Abstract][Full Text] [Related]
15. [Penicillin tolerance in group A beta-hemolytic streptococci isolated from throat cultures of children with tonsillopharyngitis].
Ciftçi E; Doğru U; Güriz H; Aysev AD; Ince E
Mikrobiyol Bul; 2002 Apr; 36(2):147-52. PubMed ID: 12652866
[TBL] [Abstract][Full Text] [Related]
16. Metaanalysis of short course antibiotic treatment for group a streptococcal tonsillopharyngitis.
Casey JR; Pichichero ME
Pediatr Infect Dis J; 2005 Oct; 24(10):909-17. PubMed ID: 16220091
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of cefadroxil, penicillin and erythromycin in the treatment of streptococcal tonsillopharyngitis.
Milatovic D
Pediatr Infect Dis J; 1991 Oct; 10(10 Suppl):S61-3. PubMed ID: 1945599
[No Abstract] [Full Text] [Related]
18. Distribution of macrolide resistance mechanisms in Bulgarian clinical isolates of Streptococcus pyogenes during the years of 2013-2016.
Muhtarova AA; Gergova RT; Mitov IG
J Glob Antimicrob Resist; 2017 Sep; 10():238-242. PubMed ID: 28735056
[TBL] [Abstract][Full Text] [Related]
19. [The frequency of group A beta-hemolytic Streptococcus in acute tonsillopharyngitis and therapy with cefadroxil, clavulanic acid-amoxicillin combination and erythromycin in patients unresponsive to procaine penicillin therapy].
Tuncer AM; Kunak B; Kirsaç N; Yeğinaltay T; Kotiloğlu G; Can R; Güngör A; Nalça M
Mikrobiyol Bul; 1987 Jul; 21(3):172-7. PubMed ID: 3332700
[TBL] [Abstract][Full Text] [Related]
20. Defining the optimum treatment regimen for azithromycin in acute tonsillopharyngitis.
Cohen R
Pediatr Infect Dis J; 2004 Feb; 23(2 Suppl):S129-34. PubMed ID: 14770076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
